- aging, implementation science, global health, HIV/AIDS, STIs, translational medicine, infectious disease
For more than 25 years, Dr. Powderly has been actively engaged in research to improve treatments for patients with HIV. His initial studies focused on evaluating drug cocktails to identify effective first-line treatment for HIV. More recently, he has also been involved in research to understand the long-term side effects of HIV medications, particularly metabolic problems like diabetes, lipid abnormalities and osteoporosis.
Dr. Powderly’s global health interests include findings solutions to develop human capital in resource-limited settings through shared educational and research endeavors.
Dr. Powderly has served in a number of leadership roles in his field, including as vice chair of the U.S. AIDS Clinical Trials Group and chair of its scientific steering committee. He has been a member of numerous advisory groups on HIV and infectious diseases for the National Institutes of Health (NIH) and the U.S. Centers for Disease Control and Prevention. He also was the first chairman of the HIV Medicine Association. From 2005-12 he was dean of the School of Medicine at University College Dublin in Ireland.
Dr. Powderly is the author of more than 300 scientific journal articles and book chapters on HIV and AIDS. He also is a fellow of the Infectious Diseases Society of America, the Royal College of Physicians of Ireland and the American Association for the Advancement of Science.